2m 2m 2m 2m 2m 2m 2m
ICECURE MEDICAL (ICCM)
NASDAQ
$0.15-$0.0007 (-0.46%)
Price as of Jun 03, 2026 7:49 PM EDT- $7.0MMarket Cap
- -86.37%1-Year Change
- Medical DevicesIndustry
ICECURE MEDICAL (ICCM)
$0.15-$0.0007 (-0.46%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.4M +2.67% | 3.3M +1.92% | 3.2M +4.67% | 3.1M -25.45% | |
Cost of Revenue | 2.2M +17.01% | 1.8M -4.61% | 1.9M +17.62% | 1.6M -15.59% | |
Gross Profit | 1.2M -15.51% | 1.5M +11.62% | 1.3M -10.03% | 1.4M -34.17% | |
Sales and Marketing Expense | 4.4M -30.78% | 6.3M +41.90% | 4.4M +38.48% | 3.2M +67.14% | |
Research and Development Expense | -7.4M +4.75% | -7.1M -14.23% | -8.3M -9.32% | -9.1M +55.23% | |
Depreciation and Amortization Expense | 295,000 -11.14% | 332,000 +2.79% | 323,000 +30.24% | 248,000 +95.28% | |
Total Operating Expenses | 4.5M +20.61% | 3.8M -9.87% | 4.2M -28.87% | 5.9M +41.99% | |
Operating Profit | -15.1M -3.84% | -15.7M +0.77% | -15.6M -6.95% | -16.7M +72.14% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 37,000 -90.21% | 378,000 -59.09% | 924,000 +486.61% | -239,000 +39.77% | |
Income before Taxes | -15.1M -3.84% | -15.7M +0.77% | -15.6M -6.95% | -16.7M +72.14% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -15.1M -1.70% | -15.3M +4.55% | -14.7M -13.70% | -17.0M +71.58% | |
Net Income from Continuing Operations Applicable to Common | -15.1M -1.70% | -15.3M +4.55% | -14.7M -13.70% | -17.0M +71.58% | |
Basic EPS and Net Income | 0.24 -20.00% | 0.30 -6.25% | 0.32 -30.43% | 0.46 +31.43% | |
Diluted EPS and Net Income | 0.24 -20.00% | 0.30 -6.25% | 0.32 -30.43% | 0.46 +31.43% | |
Basic Weighted Average Shares | 63.6M +24.97% | 50.9M +11.48% | 45.6M +23.29% | 37.0M +29.66% | |
Diluted Weighted Average Shares | 63.6M +24.97% | 50.9M +11.48% | 45.6M +23.29% | 37.0M +29.66% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.9M +17.62% | 7.6M -28.19% | 10.5M -55.48% | 23.7M -7.66% | |
Short-Term Investments | N/A N/A | N/A N/A | 529,000 N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 8.9M +17.62% | 7.6M -31.62% | 11.1M -53.24% | 23.7M -7.66% | |
Total Current Assets | 12.6M +17.21% | 10.8M -24.18% | 14.2M -49.58% | 28.1M -7.23% | |
Accumulated Depreciation | 1.1M +22.39% | 920,000 -24.53% | 1.2M +34.55% | 906,000 +204.03% | |
Property and Plant and Equipment and Net | 993,000 -20.69% | 1.3M -17.25% | 1.5M +11.58% | 1.4M +90.18% | |
Total Long-Term Assets | 1.3M -29.58% | 1.8M -18.15% | 2.2M +8.16% | 2.1M +5.05% | |
Total Assets | 13.9M +10.43% | 12.6M -23.36% | 16.4M -45.64% | 30.2M -6.48% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 4.8M -12.51% | 5.5M +42.44% | 3.9M -10.72% | 4.3M +7.86% | |
Total Long-Term Debt | 13,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 13,000 -91.93% | 161,000 -57.18% | 376,000 -12.56% | 430,000 -67.00% | |
Total Liabilities | 4.8M -15.00% | 5.7M +33.62% | 4.2M -10.89% | 4.8M +1.30% | |
Retained Earnings | -120.4M +14.29% | -105.4M +17.01% | -90.1M +19.43% | -75.4M +29.06% | |
Total Stockholders Equity | 9.1M +31.15% | 6.9M -43.26% | 12.2M -52.16% | 25.4M -5.70% | |
Total Shares Outstanding | 73.1M +29.26% | 56.6M +23.70% | 45.7M +0.23% | 45.6M +27.51% | |
Cash Flow | |||||
Cash from Operating Activities | -14.6M +16.01% | -12.6M +0.34% | -12.5M -12.39% | -14.3M +13.38% | |
Capital Expenditures | 36,000 -49.30% | 71,000 -85.21% | 480,000 -46.13% | 891,000 +67.17% | |
Cash from Investing Activities | -36,000 -108.07% | 446,000 +162.55% | -713,000 -19.98% | -891,000 -123.50% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 15.8M +72.35% | 9.2M +10,968.67% | 83,000 -99.39% | 13.6M -56.05% | |
Financials Ratio | |||||
Gross Margin | 36.28% -17.71% | 44.09% +9.51% | 40.26% -14.05% | 46.84% N/A | |
Operating Margin | -446.70% -6.34% | -476.94% -1.13% | -482.38% -11.10% | -542.59% N/A | |
Return on Assets | -113.79% +7.66% | -105.69% +68.07% | -62.89% +15.69% | -54.36% N/A | |
Return on Equity | -188.78% +17.47% | -160.70% +106.11% | -77.97% +20.27% | -64.83% N/A | |
Revenue Growth | 2.67% +39.26% | 1.92% -58.86% | 4.67% +118.34% | -25.45% N/A | |
Current Ratio | 2.61 +33.98% | 1.95 -46.77% | 3.66 -43.52% | 6.49 N/A | |
Cash Ratio | 1.84 +34.44% | 1.37 -49.58% | 2.72 -50.13% | 5.46 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow